Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Ask Theory

049: [Nuclear Medicine] Ano Ang Nuclear Medicine - At Safe Ba Talaga 'To? (with Dr. Thomas Neil Pascual)

21 Nov 2021

Description

This episode features Dr. Thomas Neil Pascual, a nuclear medicine physician and Science and Technology Fellow III for the Department of Science and Technology - Philippine Nuclear Research Institute (DOST-PNRI). He serves as a technical adviser and research coordinator, providing high-level expertise and advice to researchers while developing and implementing projects aimed at applying quality management in nuclear medicine and diagnostic imaging practices. We talked about why people tend to associate nuclear energy with destruction, the responsible use of nuclear energy to benefit the public, the field of nuclear medicine, some exciting applications of nuclear energy in health that Filipinos can look forward to, and more. How to contact Dr. Thomas: Facebook: fb.com/thomas.pascual.94 Facebook (Official Page): fb.com/DOST.STFellows For clinical consultations: www.nowserving.ph Dr. Pascual will be the resource speaker for “Nuclear Science and Technology Applications: Frontiers in Diagnostic Nuclear Medicine,” a virtual talk via Zoom and FB Live on November 26, 2021, at 8:00 AM. Register here: www.bit.ly/NSTW2021PNRIForum This episode of the Ask Theory podcast was made possible by the Department of Science and Technology, in celebration of the 2021 National Science and Technology Week (NSTW) happening on November 22-28, 2021. For more information on the 2021 NSTW, visit www.nstw.dost.gov.ph and follow the hashtags #2021NSTW, #DOSTTugonSaHamon, and #ScienceForThePeople on social media.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.